Primary endpoint met in both US trials and positive ex-US EBITDA excl. one-offs in Q4 Fourth quarter 2024Net sales for the quarter totalled MSEK 49.2 (44.5), equivalent to an increase of 10% compared ...
The global AI in medical imaging market size was valued at USD 1.28 billion in 2024 and is projected to reach around USD ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and ...